Mice with this conditional insertion, upon cre recombinase expression, produce a mutant neurogenin 3 protein in which serine has been replaced by alanine at amino acid positions 183 and 187 (S183A/S187A), eliminating a glycogen synthase kinase 3 beta (GSK3beta) consensus phosphorylation site, impairing its association with FBW7 and stabilizing the protein. The targeting construct was made by insertion of a cDNA encoding the full-length mouse protein with the introduced mutations into the Gateway compatible pROSA26-DV1 plasmid. The final construct contains a splice acceptor followed by a loxP-flanked Pgk-neor with a triple polyadenylation signal (STOP sequence), the modified Neurog3 cDNA, and an enhanced green fluorescent protein (EGFP) cDNA downstream of an internal ribosomal entry site (IRES). Deletion of the Pgk-neor-STOP by cre recombinase results in co-expression of NEUROG3-S183A/S187A and EGFP. (J:194078, J:215154)

Basic Information

Allele
Strain of Origin
Allele Type
Mutation
Inheritance
Gene Expression
Related Disease
Reference
(129S6/SvEvTac x C57BL/6NCrl)F1
Targeted
Insertion
Dominant
--
--
2

Phenotypes

Legend:
hm: homozygous
ht: heterozygous
cn: conditional genotype
cx: complex: > 1 genome feature
tg: involves transgenes
ot: other: hemizygous, indeterminate,...
(F): Female
(M): Male
phenotype observed
N: normal phenotype
(#): related diseases count
Phenotypes:
Show/Hide columns
Phenotypes

References Literature

Title
PMID
Journal
Year
IF
No Data Found!
Wechat
Comparison
Al agent
Tutorials
Back to top